Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.
<h4>Background</h4>Chlorproguanil-dapsone (Lapdap), developed as a low-cost antimalarial, was withdrawn in 2008 after concerns about safety in G6PD deficient patients. This trial was conducted in 2004 to evaluate the safety and effectiveness of CD and comparison with artemether-lumefantr...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4def0e2add1d49df9879278cc1667522 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4def0e2add1d49df9879278cc1667522 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4def0e2add1d49df9879278cc16675222021-11-18T06:52:32ZRandomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.1932-620310.1371/journal.pone.0017371https://doaj.org/article/4def0e2add1d49df9879278cc16675222011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21666744/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Chlorproguanil-dapsone (Lapdap), developed as a low-cost antimalarial, was withdrawn in 2008 after concerns about safety in G6PD deficient patients. This trial was conducted in 2004 to evaluate the safety and effectiveness of CD and comparison with artemether-lumefantrine (AL) under conditions of routine use in G6PD normal and G6PD deficient patients with uncomplicated malaria in The Gambia. We also examined the effects of a common genetic variant that affects chlorproguanil metabolism on risk of treatment failure.<h4>Methods</h4>1238 children aged 6 months to 10 years with uncomplicated malaria were randomized to receive CD or artemether-lumefantrine (AL) and followed for 28 days. The first dose was supervised, subsequent doses given unsupervised at home. G6PD genotype was determined to assess the interaction between treatment and G6PD status in their effects on anaemia. The main endpoints were clinical treatment failure by day 28, incidence of severe anaemia (Hb<5 g/dL), and haemoglobin concentration on day 3.<h4>Findings</h4>One third of patients treated with AL, and 6% of patients treated with CD, did not complete their course of medication. 18% (109/595) of children treated with CD and 6.1% (36/587) with AL required rescue medication within 4 weeks, risk difference 12% (95%CI 8.9%-16%). 23 children developed severe anaemia (17 (2.9%) treated with CD and 6 (1.0%) with AL, risk difference 1.8%, 95%CI 0.3%-3.4%, P = 0.02). Haemoglobin concentration on day 3 was lower among children treated with CD than AL (difference 0.43 g/dL, 95% CI 0.24 to 0.62), and within the CD group was lower among those children who had higher parasite density at enrollment. Only 17 out of 1069 children who were typed were G6PD A- deficient, of these 2/9 treated with CD and 1/8 treated with AL developed severe anaemia. 5/9 treated with CD had a fall of 2 g/dL or more in haemoglobin concentration by day 3.<h4>Interpretation</h4>AL was well tolerated and highly effective and when given under operational conditions despite poor adherence to the six-dose regimen. There were more cases of severe malaria and anaemia after CD treatment although G6PD deficiency was uncommon.<h4>Trial registration</h4>Clinicaltrials.gov NCT00118794.Samuel DunyoGiorgio SirugoSanie SesayCyrille BisseyeFanta NjieMajidah AdiamohDavis NwakanmaMathurin DiattaRamatoulie JanhaFatou Sisay JoofBeth TemplePaul SnellDavid ConwayRobert WaltonYin Bun CheungPaul MilliganPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 6, p e17371 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Samuel Dunyo Giorgio Sirugo Sanie Sesay Cyrille Bisseye Fanta Njie Majidah Adiamoh Davis Nwakanma Mathurin Diatta Ramatoulie Janha Fatou Sisay Joof Beth Temple Paul Snell David Conway Robert Walton Yin Bun Cheung Paul Milligan Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. |
| description |
<h4>Background</h4>Chlorproguanil-dapsone (Lapdap), developed as a low-cost antimalarial, was withdrawn in 2008 after concerns about safety in G6PD deficient patients. This trial was conducted in 2004 to evaluate the safety and effectiveness of CD and comparison with artemether-lumefantrine (AL) under conditions of routine use in G6PD normal and G6PD deficient patients with uncomplicated malaria in The Gambia. We also examined the effects of a common genetic variant that affects chlorproguanil metabolism on risk of treatment failure.<h4>Methods</h4>1238 children aged 6 months to 10 years with uncomplicated malaria were randomized to receive CD or artemether-lumefantrine (AL) and followed for 28 days. The first dose was supervised, subsequent doses given unsupervised at home. G6PD genotype was determined to assess the interaction between treatment and G6PD status in their effects on anaemia. The main endpoints were clinical treatment failure by day 28, incidence of severe anaemia (Hb<5 g/dL), and haemoglobin concentration on day 3.<h4>Findings</h4>One third of patients treated with AL, and 6% of patients treated with CD, did not complete their course of medication. 18% (109/595) of children treated with CD and 6.1% (36/587) with AL required rescue medication within 4 weeks, risk difference 12% (95%CI 8.9%-16%). 23 children developed severe anaemia (17 (2.9%) treated with CD and 6 (1.0%) with AL, risk difference 1.8%, 95%CI 0.3%-3.4%, P = 0.02). Haemoglobin concentration on day 3 was lower among children treated with CD than AL (difference 0.43 g/dL, 95% CI 0.24 to 0.62), and within the CD group was lower among those children who had higher parasite density at enrollment. Only 17 out of 1069 children who were typed were G6PD A- deficient, of these 2/9 treated with CD and 1/8 treated with AL developed severe anaemia. 5/9 treated with CD had a fall of 2 g/dL or more in haemoglobin concentration by day 3.<h4>Interpretation</h4>AL was well tolerated and highly effective and when given under operational conditions despite poor adherence to the six-dose regimen. There were more cases of severe malaria and anaemia after CD treatment although G6PD deficiency was uncommon.<h4>Trial registration</h4>Clinicaltrials.gov NCT00118794. |
| format |
article |
| author |
Samuel Dunyo Giorgio Sirugo Sanie Sesay Cyrille Bisseye Fanta Njie Majidah Adiamoh Davis Nwakanma Mathurin Diatta Ramatoulie Janha Fatou Sisay Joof Beth Temple Paul Snell David Conway Robert Walton Yin Bun Cheung Paul Milligan |
| author_facet |
Samuel Dunyo Giorgio Sirugo Sanie Sesay Cyrille Bisseye Fanta Njie Majidah Adiamoh Davis Nwakanma Mathurin Diatta Ramatoulie Janha Fatou Sisay Joof Beth Temple Paul Snell David Conway Robert Walton Yin Bun Cheung Paul Milligan |
| author_sort |
Samuel Dunyo |
| title |
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. |
| title_short |
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. |
| title_full |
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. |
| title_fullStr |
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. |
| title_full_unstemmed |
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. |
| title_sort |
randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the gambia. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/4def0e2add1d49df9879278cc1667522 |
| work_keys_str_mv |
AT samueldunyo randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT giorgiosirugo randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT saniesesay randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT cyrillebisseye randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT fantanjie randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT majidahadiamoh randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT davisnwakanma randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT mathurindiatta randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT ramatouliejanha randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT fatousisayjoof randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT bethtemple randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT paulsnell randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT davidconway randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT robertwalton randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT yinbuncheung randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia AT paulmilligan randomizedtrialofsafetyandeffectivenessofchlorproguanildapsoneandlumefantrineartemetherforuncomplicatedmalariainchildreninthegambia |
| _version_ |
1718424291549118464 |